MPS Ltd (MPSLTD) is currently trading at 2,265.00 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.

MPS Limited is an AI-first knowledge company providing content creation, publishing production, research workflows, education solutions, corporate learning, and trusted clinical information platforms for publishers, universities, enterprises, and healthcare customers. Its operations span the knowledge lifecycle, from authoring and validation to distribution, learning, and point-of-care application. MPS Limited delivered its most profitable first half, with revenue rising 17.8% to INR 448.5 crores and EBITDA increasing 39% to INR 154 crores. EBITDA margin reached 34.3%, reflecting significant operating leverage as company-owned platforms, AI tools, and established delivery teams absorb incremental business. Research is benefiting from the growing need to detect paper mills, machine-written manuscripts, and integrity concerns. Research margins reached 48.2%, while research revenue excluding AJE grew approximately 22% without acquisitions, suggesting organic demand is strengthening around trusted peer review and quality assurance. Education has become a meaningful second pillar at 30.6% of group revenue, supported by US state adoption cycles and Unbound Medicine subscriptions. Corporate Learning is being repositioned around healthcare workforce training, where MPS combines clinical content, learning platforms, and mobile support to address nurse shortages and retention. MPS Limited enters the second half with zero debt, INR 163 crores of cash, lower customer concentration, and a raised FY27 EBITDA floor of INR 310 crores. Growth remains weighted toward the fourth quarter because recently won mandates begin billing later, making execution and acquisition discipline important watchpoints.

Over the past 52 weeks, MPS Ltd has traded between a low of ₹1,340.00 and a high of ₹2,980.00. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.

MPS Ltd has a market capitalization of approximately 3,878.32. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.

MPS Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 20.40 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.

Based on its market capitalization of 3,878.32 Cr, MPS Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.

MPS Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.

The Price-to-Earnings (PE) ratio of MPS Ltd is 20.40. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.

MPS said it acquired AJE in February 2024 for around Rs 70 crore. Management used that purchase price as the basis for its stated two-to-two-and-a-half-year payback calculation.

Management said no such assumption should be made. MPS said the Rs 1,500 crore FY28 target has always combined organic growth with acquisitions, and it has not disclosed how much of that goal the current business could achieve alone.

MPS expects FY27 EBITDA of at least Rs 310 crore. Management raised the floor after H1 FY27 EBITDA increased 39% to Rs 154 crore, from an earlier expectation to comfortably exceed Rs 300 crore.

Research Solutions reported a 49.25% EBITDA margin excluding AJE in Q2 FY27. The comparable margin was 46.35% in Q2 FY26, a rise of 2.90 percentage points.